Jiangxi Fushine Pharmaceut (300497.SZ) traded flat 0 % during a 24 hours period ending at 08:00 AM Central Europe on Wednesday 28th. One Jiangxi Fushine Pharmaceut stock can currently be bought for about CNY 13.29 on popular exchanges. Current supply of Jiangxi Fushine Pharmaceut stocks is 538.5 mn. Jiangxi Fushine Pharmaceut has a current market capitalization of CNY 7.1 bn and approximately CNY 278 mn worth of Jiangxi Fushine Pharmaceut was traded on exchanges in the last 24 hours. Since last month end, Jiangxi Fushine Pharmaceut has traded -24.19 % down. Simple moving average of last 200 days is at CNY 17.99. The highest price of past 52 weeks was recorded at CNY 24.18 on 07/02/2026. 52 weeks low was at CNY 9.92 on 10/30/2025.
Here is how related stocks have performed in the past 24 hours:
Harbin Electric Jiam (000922.SZ) traded flat 0 % and now trades at CNY 10.22. Current market capitalisation for Harbin Electric Jiam is CNY 8.6 bn. Harbin Electric Jiam has a current price to earnings ratio of 28.49.
Cq Pharmaceutical (000950.SZ) traded flat 0 % and now trades at CNY 5.01. Cq Pharmaceutical has a market capitalisation of CNY 8.6 bn. Cq Pharmaceutical has a current price to earnings ratio of 26.98.
Aa Industrial Belting (603580.SS) traded flat 0 % and now trades at CNY 63.85. Aa Industrial Belting has a market capitalisation of CNY 8.5 bn. Current price/earnings ratio for Aa Industrial Belting is 204.82.
Shanghai Chlor-alkali Chem (600618.SS) traded flat 0 % and now trades at CNY 9.06. Shanghai Chlor-alkali Chem has a market capitalisation of CNY 8.6 bn. Shanghai Chlor-alkali Chem has a current price to earnings ratio of 13.74.
Shenzhen Zhenye (000006.SZ) traded flat 0 % and now trades at CNY 6.4. Shenzhen Zhenye has a market capitalisation of CNY 8.5 bn.
About Jiangxi Fushine Pharmaceut
Jiangxi Fushine Pharmaceutical Co., Ltd. is a health care company operating in the pharmaceutical industry. The company, previously known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd, specializes in conducting research, development, manufacturing, and selling APIs and pharmaceutical intermediates both nationally and internationally. Their product range includes penicillin, carbapenem, and other drugs. Additionally, they provide contract research, development, and manufacturing services. The company was founded in 2002 and has its main operations in Jingdezhen, China. Their website is accessible under www.fushine.cn and they are listed on the Shenzhen Stock Exchange.